PFE as of Nov 1 · 02:09 ET

PFENYSEPharmaceutical Preparations

Pfizer Inc · Brief

Next report

2 days

Nov 3 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±2.7%implied · report alone

29.6931.35

straddle ±3.7%

spot 30.52exp Nov 6ATM strike 30.5ATM straddle 1.34IV 40%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

2 of 8≥ implied

avg implied: ±3.6%
avg realized: ±2.2%

Oct 29 '24±3.4%▼−1.39%×0.41

Feb 4 '25±3.5%▼−1.26%×0.36

Apr 29 '25±3.4%▲+3.21%×0.96

Aug 5 '25±4.1%▲+5.19%×1.28

Q3 FY25±4.2%▼−1.46%×0.35

Feb 3 '26±3.2%▼−3.34%×1.05

Q1 FY26±3.5%▲+0.57%×0.16

Q2 FY26±3.3%▲+1.52%×0.46

quarterimplied−10%0+10%realized×

Q2 FY26±3.3%▲+1.52%×0.46

Q1 FY26±3.5%▲+0.57%×0.16

Feb '26±3.2%▼−3.34%×1.05

Q3 FY25±4.2%▼−1.46%×0.35

Aug '25±4.1%▲+5.19%×1.28

Apr '25±3.4%▲+3.21%×0.96

2 older reports

Feb '25±3.5%▼−1.26%×0.36

Oct '24±3.4%▼−1.39%×0.41

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2 of 4

21customers disclosing PFE as a supplierSEC filings

12.00%of Nektar Therapeutics's revenue from PFESEC filings

Bear2 of 3

74managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

6 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

PFE report session

Suppliers 1

ARVNArvinas×0.91

Customers 1

ICUIICU Medical×0.48

× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 20impliedImplied move: ±4.7% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.